Cargando…

A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients

Accurate diagnosis of colorectal cancer (CRC) still relies on invasive colonoscopy. Noninvasive methods are less sensitive in detecting the disease, particularly in the early stage. In the current work, a metabolomics analysis of fecal samples was carried out by ultra-high-performance liquid chromat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Telleria, Oiana, Alboniga, Oihane E., Clos-Garcia, Marc, Nafría-Jimenez, Beatriz, Cubiella, Joaquin, Bujanda, Luis, Falcón-Pérez, Juan Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229737/ https://www.ncbi.nlm.nih.gov/pubmed/35736483 http://dx.doi.org/10.3390/metabo12060550

Ejemplares similares

A Novel Approach on the Use of Samples from Faecal Occult Blood Screening Kits for Metabolomics Analysis: Application in Colorectal Cancer Population
por: Albóniga, Oihane E., et al.
Publicado: (2023)

Interplay between Genome, Metabolome and Microbiome in Colorectal Cancer
por: Garcia-Etxebarria, Koldo, et al.
Publicado: (2021)

Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer
por: Clos-Garcia, Marc, et al.
Publicado: (2020)

Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer
por: Cubiella, Joaquin, et al.
Publicado: (2018)

Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis
por: Kim, Minsuk, et al.
Publicado: (2020)

Polyprev: Randomized, Multicenter, Controlled Trial Comparing Fecal Immunochemical Test with Endoscopic Surveillance after Advanced Adenoma Resection in Colorectal Cancer Screening Programs: A Study Protocol
por: Regueiro, Cristina, et al.
Publicado: (2021)

Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study
por: Herrero, Jesús-Miguel, et al.
Publicado: (2018)

Impact of the faecal immunochemical test on colorectal cancer survival
por: Gutierrez-Stampa, María Angeles, et al.
Publicado: (2020)

Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations
por: Sinha, Rashmi, et al.
Publicado: (2016)

Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas
por: Gallardo-Gómez, María, et al.
Publicado: (2023)

Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test
por: Gutierrez-Stampa, María Angeles, et al.
Publicado: (2020)

Comprehensive Mutation Analysis in Colorectal Flat Adenomas
por: Voorham, Quirinus J. M., et al.
Publicado: (2012)

Value of Serum NEUROG1 Methylation for the Detection of Advanced Adenomas and Colorectal Cancer
por: Otero-Estévez, Olalla, et al.
Publicado: (2020)

Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma
por: Zhang, Yuhan, et al.
Publicado: (2021)

Untargeted Metabolomics Reveals Major Differences in the Plasma Metabolome between Colorectal Cancer and Colorectal Adenomas
por: Gumpenberger, Tanja, et al.
Publicado: (2021)

The Performance of Three-Sample Qualitative Immunochemical Fecal Test to Detect Colorectal Adenoma and Cancer in Gastrointestinal Outpatients: An Observational Study
por: Wu, Dong, et al.
Publicado: (2014)

Impact of Sample Storage on the NMR Fecal Water Metabolome
por: O’Sullivan, Victoria, et al.
Publicado: (2018)

Targeted metabolomics analysis of nucleosides and the identification of biomarkers for colorectal adenomas and colorectal cancer
por: Zheng, Weifang, et al.
Publicado: (2023)

Analysis of the Heterogeneous Distribution of Amiloride and Propranolol in Dried Blood Spot by UHPLC-FLD and MALDI-IMS
por: Uribe, Beatriz, et al.
Publicado: (2019)

Impact of the COVID-19 Pandemic on the Diagnosis of Colorectal Cancer within a Population-Based Organized Screening Program
por: Cubiella, Joaquín, et al.
Publicado: (2023)

Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer
por: Kim, Eun Ran, et al.
Publicado: (2019)

Faecal immunochemical test outside colorectal cancer screening?
por: Pin-Vieito, Noel, et al.
Publicado: (2021)

Fecal DNA Testing of TWIST1 Methylation Identifies Patients With Advanced Colorectal Adenoma Missed by Fecal Immunochemical Test for Hemoglobin
por: Suehiro, Yutaka, et al.
Publicado: (2020)

Describing the fecal metabolome in cryogenically collected samples from healthy participants
por: Trošt, Kajetan, et al.
Publicado: (2020)

Genetic Variants Associated with Colorectal Adenoma Susceptibility
por: Abulí, Anna, et al.
Publicado: (2016)

HPLC–(Q)-TOF-MS-Based Study of Plasma Metabolic Profile Differences Associated with Age in Pediatric Population Using an Animal Model
por: Albóniga, Oihane E., et al.
Publicado: (2022)

Performance of the Use of Genetic Information to Assess the Risk of Colorectal Cancer in the Basque Population
por: Garcia-Etxebarria, Koldo, et al.
Publicado: (2022)

Genetic Variants as Predictors of the Success of Colorectal Cancer Treatments
por: Garcia-Etxebarria, Koldo, et al.
Publicado: (2023)

Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study
por: Goedert, James J., et al.
Publicado: (2015)

Reusing a prepaid health plan’s fecal immunochemical tests for microbiome associations with colorectal adenoma
por: Goedert, James J., et al.
Publicado: (2022)

Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community‐based cohort study
por: Pin‐Vieito, Noel, et al.
Publicado: (2021)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples
por: Gallardo-Gómez, María, et al.
Publicado: (2018)

The Approach to Sample Acquisition and Its Impact on the Derived Human Fecal Microbiome and VOC Metabolome
por: Couch, Robin D., et al.
Publicado: (2013)

An LC-QToF MS based method for untargeted metabolomics of human fecal samples
por: Cheng, Ken, et al.
Publicado: (2020)

NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer
por: Lin, Yan, et al.
Publicado: (2016)

Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis
por: Du, Xinhao, et al.
Publicado: (2022)

Immunochemical Fecal Occult Blood Test for Detection of Advanced Colonic Adenomas and Colorectal Cancer: Comparison with Colonoscopy Results
por: Viana Freitas, Bianca Rosa, et al.
Publicado: (2013)

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
por: Gies, Anton, et al.
Publicado: (2021)

Targeted depletion of pks+ bacteria from a fecal microbiota using specific antibodies
por: Blanco-Míguez, Aitor, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aq7ac8tdvgneiraigo0nij0r8g